{"database": "lobbying", "table": "lobbying_activities", "rows": [[1623844, "712ed119-5837-4efb-9ddd-4e63749f4837", "Q4", "EMPIRE CONSULTING GROUP", 400703105, "PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA", 2014, "fourth_quarter", "PHA", "Issues relating to the Medicare Prescription Drug Act; 340B Drug Pricing Program and drug pricing generally; health disparities in diverse communities.", "HOUSE OF REPRESENTATIVES", 40000, null, 0, 0, "2015-01-16T10:15:21.113000-05:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1623844"], "units": {}, "query_ms": 370.42188306804746, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}